My take: The release states TLX101 is currently second line treatment. TLX are stopping this second line trial and plan to move it into first line therapy trial on encouraging results: Whilst a small study of ten patients, promising overall survival and anti-tumour response observed from longitudinal imaging supports the decision to progress this candidate into an earlier line of therapy.
Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update, page-20
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.94 |
Change
0.440(2.05%) |
Mkt cap ! $7.342B | |||
| Open | High | Low | Value | Volume |
| $21.70 | $22.08 | $21.47 | $24.93M | 1.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1027 | $21.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.00 | 63279 | 3 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |